DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
Saxenda (liraglutide) for chronic weight management. Covered with PA under Aetna.
Aetna (CVS Health subsidiary) covers GLP-1s through standard commercial formularies and Aetna Medicare Advantage. Weight-loss indication generally requires BMI documentation.
BMI ≥ 30 or BMI ≥ 27 with comorbidity.
Manufacturer card brings copay to $25/mo for eligible patients.
Saxenda is increasingly de-prioritized in favor of weekly Wegovy. PA approval is lower than Wegovy on identical criteria.
Editorial summary, not legal or medical advice. Insurance formularies change quarterly. Verify with your specific plan member services before relying on any single source. Copay ranges reflect typical commercial plans; your plan may differ.